Loading...
Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole
BACKGROUND: Brexpiprazole and cariprazine are the latest US Food and Drug Administration approved atypical antipsychotics available in the United States. Both function as partial agonists of the dopamine-2 receptor (D(2)R), a mechanism of action shared with aripiprazole. However, all three differ in...
Saved in:
| Published in: | Ther Adv Psychopharmacol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228714/ https://ncbi.nlm.nih.gov/pubmed/28101322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125316672136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|